Rare diseases
Investigational molecules
Locations
Back to France951 clinical trials in Nantes, France across 2 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in FranceEssaisCliniques.fr(opens in a new tab)A study to test if BHV-8000 is effective and safe for adults with early Parkinson's disease
FranceStudy of N-803, tislelizumab and docetaxel combination versus docetaxel alone for patients with advanced or metastatic non-small cell lung cancer resistant to immune checkpoint inhibitors
FranceStudy of Olpasiran to prevent first major cardiovascular events in people with high levels of lipoprotein(a)
FranceStudy of Avacopan Safety and Effectiveness in Patients with ANCA-associated Vasculitis
FranceStudy on the Effectiveness of JNJ-77242113 and Deucravacitinib for Treating Moderate to Severe Plaque Psoriasis in Adults
FranceFranceRamantamig (JNJ-79635322) with drug combination versus standard therapy in newly diagnosed multiple myeloma patients not eligible for stem cell transplant
FranceA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
FranceClinical Trial of Human Normal Immunoglobulin to Prevent Infections in Patients with Secondary Antibody Deficiency due to CLL, Multiple Myeloma or Non‑Hodgkin Lymphoma
FranceStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
FrancePhase II study of fixed‑dose, accelerated ramp‑up epcoritamab plus lenalidomide in patients with relapsed/refractory large B‑cell lymphoma after CAR‑T therapy
FranceFranceThe busiest research cities in the country
What the registry says about research in the country
Advanced research focusing on multiple myeloma, leukemia, and various lymphomas. Studies are evaluating novel treatment combinations and therapeutic approaches for blood cancers.
Innovative trials exploring combinations of targeted therapies and immunotherapies to improve patient outcomes.
Comprehensive studies on preventive measures against viral infections, including trials for vaccines targeting CMV, yellow fever, and mpox.
Focus on developing and evaluating new vaccine formulations and delivery methods.
Research investigating treatments for inflammatory bowel diseases and multiple sclerosis, including innovative approaches like fecal microbiota transplantation.
Exploring novel therapeutic options and treatment de-escalation strategies.
Studies addressing postoperative care and management of severe conditions in intensive care settings, including burns and immune suppression.
Evaluating new approaches to improve patient comfort and outcomes in critical care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
